Tech Company Financing Transactions
NeoRx Funding Round
NeoRx closed a $65 million funding round on 4/27/2006. Investors included MPM Capital, Abingworth and Bay City Capital.
Transaction Overview
Company Name
Announced On
4/27/2006
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing enables us to pursue our strategic objective of building a diverse pipeline and repositioning the company as a specialty pharmaceutical company focused on oncology
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
300 Elliott Avenue West 500
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Email Address
Not Recorded
Overview
NeoRx is a specialty pharmaceutical company dedicated to the discovery, development and commercialization of oncology drugs that impact the lives of individuals afflicted with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/26/2006: OptiMedica venture capital transaction
Next: 4/28/2006: DVDPlay venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs